The CRISPR-Cas9 system offers groundbreaking genome editing capabilities, yet off-target cleavage raises concerns about ...

Fintel reports that on February 14, 2025, Evercore ISI Group upgraded their outlook for CRISPR Therapeutics (NasdaqGM:CRSP) ...

Yibin Kang, a professor in the Department of Molecular Biology, discussed new breast cancer research in his lab.

In a study published in Nature Structural and Molecular Biology, scientists from the Department of Medical Biochemistry and ...

CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at Needham ...

MaizeCODE is a genomic project analyzing the genetic basis of maize domestication. Researchers identified key regulatory ...

China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...

Researchers at Baylor College of Medicine, the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas ...

Scientists around St. Louis worry their medical research will lose key funding as the National Institutes of Health (NIH) announced changes on how finance grants can be ...

Scott Shafer took a break from dating. Then he met his future wife. Now, they both work at UNK. He's the head UNK tennis ...

A CRISPR-based system that erases itself from fly populations may offer a safer approach to tackling insecticide resistance ...

Researchers have revealed new details about the CRISPR-Cas5-HNH/Cascade complex, a variant of the type I-E CRISPR-Cas system, ...